Melanoma – (locally advanced or metastatic) | XPORT-MEL-033
Indication: Melanoma
Title: Safety and Efficacy of Selinexor in Combination with Pembrolizumab in Recurrent Advanced Melanoma
Drug: Selinexor
Please visit clinicaltrials.gov to learn more about this trial
Phase I | Phase II | Phase III |
---|---|---|
Phase I | Phase II | Phase III |